Feedback
The current prices are delayed. Login to see live prices.
Glenmark Pharmaceuticals Ltd.
(GLENMARK)
10123456789,001234567895012345678970123456789.2012345678900123456789
-13.90 (-1.30%)
Add
1D
5D
1M
3M
1Y
5Y
MAX
Today's low
₹1,054.50
Today's high
₹1,081.6
52 week low
₹536.25
52 week high
₹1,098
Open
₹1,075
Prev Close
₹1,071.1
Volume (shares)
952,244
Total Trading Value
101.99 Cr
Technicals
SMA
Value
Signal
12-SMA
1,054.73
Bullish
20-SMA
1,038.65
Bullish
50-SMA
968.27
Bullish
100-SMA
912.37
Bullish
200-SMA
845.62
Bullish
Valuations
PE Chart
Median PE (M) : 26.68
Current PE is higher than median PE.
PB Chart
Median PB (M) : 2.53
Current PB is higher than median PB.
Fundamentals
Market Cap
₹29,834.18 Cr
Enterprise Value
₹32,712.20 Cr
No. of Shares
28.22 Cr
P/E Ratio(TTM)
0
RoE
4.07%
Debt/Equity
0.46
Revenue vs Profitability (In Cr.)
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Revenue
Profit
Margins (%)
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Gross Margin
Net Margin
Ratios
Debt/Equity
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Debt to Equity
ROE vs ROCE
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE
ROCE
Shareholding
Shareholding Pattern
Public : 18.58%
FII : 21.38%
Others : 0%
DII : 13.4%
Promoter : 46.64%
Shareholding History
Dec, 2022Mar, 2023Jun, 2023Sep, 2023Dec, 2023Mar, 2024
Discussions
• Apr 29 4:28 PM
𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Glenmark Pharmaceuticals has received approval from th...read more
• Apr 29 3:43 PM
𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Glenmark Pharmaceuticals Ltd. has received final appro...read more
• Apr 22 5:15 PM
• Apr 14 6:14 PM
• Apr 12 3:20 PM
• Apr 9 11:31 PM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
1
• Apr 9 8:31 PM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
• Apr 9 5:31 PM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
2
• Apr 9 3:53 PM
𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Lupin Ltd., Glenmark Pharmaceuticals Ltd., and Natco P...read more
• Apr 9 2:31 PM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
• Apr 9 11:31 AM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
• Apr 9 8:31 AM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
• Apr 9 5:31 AM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
• Apr 9 2:31 AM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
• Apr 8 11:31 PM
KRChoksey target on GLENMARK
Date: 05-Apr-24...read more
• Apr 8 8:38 PM
𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Nirma Limited has completed the purchase of 75% of Gle...read more
• Apr 4 5:28 PM
Buy
Glenmark@1000ce...read more
• Mar 19 12:02 AM
• Mar 14 10:51 PM
• Mar 8 12:13 PM
𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Shilpa Rout, Derivative Lead Analyst and AVP - Researc...read more
1
• Mar 5 2:17 PM
• Feb 27 1:11 AM
• Feb 26 2:19 PM
• Feb 26 3:14 AM
💥INTRADAY TRADE💥
STOCK-:@GLENMARK...read more
1
• Feb 23 5:33 PM
𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• Cipla's inhaler Foracort was the third-bestselling the...read more
4
• Feb 23 1:53 PM
𝗡𝗲𝘄𝘀 𝗦𝘂𝗺𝗺𝗮𝗿𝘆
• KR Choksey has recommended an Accumulate rating on Gle...read more
Load More Posts
Frequently Asked Questions (FAQs)
How can I take a Paper Trade/Virtual trade in Glenmark Pharmaceuticals Ltd.?
To place a Paper Trade/Virtual trade on Glenmark Pharmaceuticals Ltd., you can sign up/login on Frontpage for absolutely free. Then, you can paper trade with real-time prices.
What is the Share Price of Glenmark Pharmaceuticals Ltd. ?
The share prices are volatile and fluctuate throughout the trading hours. The share price of Glenmark Pharmaceuticals Ltd. is Rs 1071.1 as of 30 April 2024.
What is the Market Capitalization of Glenmark Pharmaceuticals Ltd. ?
The current market cap of Glenmark Pharmaceuticals Ltd. is ₹29834.18 Cr. Market capitalisation is calculated by multiplying the current share price with the total number of shares.
What are the PE and PB ratios of Glenmark Pharmaceuticals Ltd.?
Glenmark Pharmaceuticals Ltd. has a price-to-earnings (PE) ratio of 0 and a price-to-book (PB) ratio of 3.36.
What is the 52-week high/low of Glenmark Pharmaceuticals Ltd.?
The 52-week high of Glenmark Pharmaceuticals Ltd. is Rs 1098 and the 52-week low is Rs 536.25
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
FrontPage © 2024